Riskpilot← Back to searchSign inGet full accessSPECIALLÆGESELSKABET SANTOFT ApS
APSActiveCVR 33641265Violvej 28Medical specialists activities · NACE 8622Est. 20111 employees
Revenue 2024
DKK -140K
-19% vs 2023
EBITDA margin
612.8%
+15% vs 2023
Equity ratio
26.5%
Financial strength
Net profit 2024
DKK 21K
-83% vs 2023
| Revenue | DKK -140K | -19% |
| EBITDA | DKK -860K | +15% |
| Net profit | DKK 21K | -83% |
| Total assets | DKK 788K | -17% |
| Equity | DKK 209K | -16% |
| Employees | 1 | — |
Legal name
SPECIALLÆGESELSKABET SANTOFT ApS
CVR number
33641265
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
2. maj 2011
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den adm direktør.
Company purpose
Selskabets formål er at drive speciallægevirksomhed og virksomhed, der er
naturligt forbundet hermed.
Address
Violvej 28
Phone
+4522547654
Email
sannedenmark@me.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | -79 | -84 | -172 | -140 |
| Staff expenses | -0 | -410 | -862 | -833 | -719 |
| EBITDA | 0 | -489 | -946 | -1.005 | -860 |
| Depreciation & amort. | -1 | -29 | -0 | -0 | -0 |
| EBIT | -1 | -517 | -946 | -1.005 | -860 |
| Net financials | 0 | 696 | 1.059 | 1.160 | 885 |
| Profit before tax | -1 | 179 | 113 | 154 | 26 |
| Tax | -0 | 54 | 16 | 33 | 5 |
| Net profit | -1 | 125 | 97 | 121 | 21 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 29 | 1.156 | 1.110 | 951 | 788 |
| Equity | -8 | 165 | 187 | 249 | 209 |
| Long-term debt | 0 | 290 | 190 | 113 | 13 |
| Short-term debt | 37 | 701 | 733 | 588 | 566 |
| Total debt | 37 | 991 | 923 | 701 | 579 |
EBITDA margin
-85957600.0%
This company
15.8%
Market median
-544035543% vs market
20202024
Equity ratio
26.5%
This company
38.2%
Market median
-31% vs market
20202024
Return on equity
9.9%
This company
18.4%
Market median
-46% vs market
20202024
Net profit margin
2066600.0%
This company
8.1%
Market median
+25513480% vs market
20202024
Asset turnover
-0.18×
This company
1.12×
Market median
-116% vs market
20202024
Debt / equity
2.77×
This company
0.62×
Market median
-347% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-10-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ST Chief Executive Officer | Chief Executive Officer | 2011 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2021 | |
| Company | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Santoft Holding ApS
SPECIALLÆGESELSKABET SANTOFT ApS Board members of SPECIALLÆGESELSKABET SANTOFT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sanne Toftgaard Christensen | Chief Executive Officer | 0 companies |